Stericycle (NASDAQ: SRCL) is one of 20 public companies in the “Waste Management, Disposal & Recycling Services” industry, but how does it compare to its rivals? We will compare Stericycle to similar businesses based on the strength of its institutional ownership, profitability, analyst recommendations, dividends, earnings, risk and valuation.
Valuation & Earnings
This table compares Stericycle and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Stericycle||$3.56 billion||$206.35 million||-118.17|
|Stericycle Competitors||$850.65 million||$28.19 million||162.89|
Insider and Institutional Ownership
94.6% of Stericycle shares are owned by institutional investors. Comparatively, 53.0% of shares of all “Waste Management, Disposal & Recycling Services” companies are owned by institutional investors. 3.5% of Stericycle shares are owned by company insiders. Comparatively, 12.3% of shares of all “Waste Management, Disposal & Recycling Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Volatility and Risk
Stericycle has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. Comparatively, Stericycle’s rivals have a beta of 0.72, meaning that their average stock price is 28% less volatile than the S&P 500.
This is a summary of recent recommendations for Stericycle and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Stericycle presently has a consensus target price of $75.90, indicating a potential upside of 12.68%. As a group, “Waste Management, Disposal & Recycling Services” companies have a potential upside of 7.99%. Given Stericycle’s higher possible upside, research analysts clearly believe Stericycle is more favorable than its rivals.
This table compares Stericycle and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Stericycle beats its rivals on 7 of the 13 factors compared.
Stericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.
What are top analysts saying about Stericycle Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stericycle Inc. and related companies.